Liquidia (NASDAQ:LQDA) Trading Down 10.8%

Liquidia Co. (NASDAQ:LQDA) was down 10.8% during trading on Wednesday . The stock traded as low as $11.11 and last traded at $11.44. Approximately 657,321 shares traded hands during mid-day trading, a decline of 24% from the average daily volume of 866,232 shares. The stock had previously closed at $12.83.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on LQDA shares. Oppenheimer started coverage on Liquidia in a research report on Tuesday, June 25th. They issued a “market perform” rating for the company. HC Wainwright reissued a “buy” rating and set a $32.00 price objective on shares of Liquidia in a report on Wednesday, July 10th. Finally, Needham & Company LLC restated a “buy” rating and issued a $28.00 target price on shares of Liquidia in a report on Thursday. One investment analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $21.60.

Liquidia Trading Up 0.8 %

The stock has a 50 day simple moving average of $12.68 and a 200-day simple moving average of $13.43. The firm has a market capitalization of $846.62 million, a P/E ratio of -7.04 and a beta of 0.32.

Liquidia (NASDAQ:LQDA) last announced its earnings results on Monday, May 13th. The company reported ($0.54) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.32) by ($0.22). Liquidia had a negative net margin of 674.42% and a negative return on equity of 177.83%. The business had revenue of $2.97 million for the quarter, compared to the consensus estimate of $4.31 million. As a group, sell-side analysts expect that Liquidia Co. will post -1.32 earnings per share for the current fiscal year.

Insider Activity

In related news, CFO Michael Kaseta sold 3,906 shares of the firm’s stock in a transaction on Friday, July 12th. The stock was sold at an average price of $12.53, for a total value of $48,942.18. Following the transaction, the chief financial officer now directly owns 312,389 shares of the company’s stock, valued at approximately $3,914,234.17. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other Liquidia news, CEO Roger Jeffs sold 8,053 shares of Liquidia stock in a transaction that occurred on Friday, July 12th. The shares were sold at an average price of $12.53, for a total transaction of $100,904.09. Following the transaction, the chief executive officer now owns 818,932 shares of the company’s stock, valued at $10,261,217.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Michael Kaseta sold 3,906 shares of the company’s stock in a transaction that occurred on Friday, July 12th. The stock was sold at an average price of $12.53, for a total transaction of $48,942.18. Following the completion of the transaction, the chief financial officer now owns 312,389 shares of the company’s stock, valued at $3,914,234.17. The disclosure for this sale can be found here. Insiders sold a total of 17,731 shares of company stock valued at $226,733 in the last 90 days. Company insiders own 31.60% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. American International Group Inc. increased its stake in Liquidia by 5.2% in the 1st quarter. American International Group Inc. now owns 24,806 shares of the company’s stock worth $366,000 after buying an additional 1,215 shares in the last quarter. Bleakley Financial Group LLC boosted its stake in shares of Liquidia by 6.6% in the first quarter. Bleakley Financial Group LLC now owns 33,250 shares of the company’s stock worth $490,000 after acquiring an additional 2,057 shares during the period. Fortitude Family Office LLC purchased a new stake in shares of Liquidia during the fourth quarter worth about $26,000. SG Americas Securities LLC raised its stake in Liquidia by 17.4% during the 4th quarter. SG Americas Securities LLC now owns 15,540 shares of the company’s stock valued at $187,000 after purchasing an additional 2,298 shares during the period. Finally, Hilltop National Bank purchased a new position in Liquidia in the 2nd quarter worth approximately $33,000. Hedge funds and other institutional investors own 64.54% of the company’s stock.

About Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).